Leo loses appeal against UK's most serious drug marketing breach as it’s censured for 'extremely concerning matter' – FiercePharma

Pharmaceutical company Leo has lost an appeal against what is considered the UK’s most severe drug marketing breach. The company was criticised for an ‘extremely concerning matter’ and held responsible for concealing safety warnings on a dermatology drug.